Aaron Kowalski: Leading the Fight Against Type 1 Diabetes

Aaron Kowalski, Ph.D., is a prominent figure in the fight against Type 1 diabetes. As the CEO of JDRF, a global leader in T1D research and advocacy, Dr. Kowalski plays a crucial role in driving strategies to accelerate progress towards finding cures for the disease. His dedication and leadership have made a significant impact on the diabetes community and have inspired many to join the fight against this widespread condition.

Born and raised in Wausau, Wisconsin, Aaron Kowalski developed a passion for science and research at a young age. After earning his Ph.D. in molecular genetics from the University of Wisconsin-Madison, he dedicated his career to studying diabetes and finding innovative solutions to improve the lives of those affected by the disease.

In his role as CEO of JDRF, Dr. Kowalski works tirelessly to advance research initiatives and advocate for policies that support individuals living with T1D. Under his leadership, JDRF has funded groundbreaking research projects, clinical trials, and educational programs aimed at improving outcomes for people with diabetes.

One of Dr. Kowalski's key priorities is to address the rising cost of insulin and ensure access to affordable diabetes care for all individuals. He believes that innovative solutions, such as Civica's new low-cost insulin, can help alleviate the insulin pricing crisis and make life-saving medications more accessible to those in need.

Dr. Kowalski's commitment to finding a cure for T1D has earned him recognition as a leading advocate in the diabetes community. His work has inspired hope and progress in the fight against diabetes, and his dedication to improving the lives of individuals with the disease has made a lasting impact on the healthcare industry.